Point Biopharma Global Inc (PNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2006 | 12-2005 | 12-1998 | 12-1997 | 12-1996 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 0 | 0 | 23,030 | 20,110 | 36,245 |
| TOTAL | $N/A | $N/A | $23,030 | $20,110 | $36,245 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 280,950 | 262,977 | 239,422 |
| Investments And Advances | 0 | 0 | 28,650 | 13,631 | 9,548 |
| Other Non-Current Assets | 0 | 0 | 40,890 | 36,676 | 35,543 |
| TOTAL | $N/A | $N/A | $350,490 | $313,284 | $284,513 |
| Total Assets | $N/A | $N/A | $373,520 | $333,394 | $320,758 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 81,340 | 24,776 | 38,721 |
| Accounts payable and accrued liabilities | 0 | 0 | 22,370 | 18,448 | 19,945 |
| Accrued Expenses | N/A | N/A | 3,570 | 5,823 | 5,688 |
| Other current liabilities | N/A | N/A | 1,920 | 1,802 | 4,019 |
| TOTAL | $N/A | $N/A | $115,400 | $57,637 | $92,898 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $75,380 | $65,584 | $61,671 |
| Total Liabilities | $N/A | $N/A | $190,780 | $123,221 | $154,569 |
| Shareholders' Equity | |||||
| Common Shares | N/A | N/A | 52,040 | 48,721 | 48,040 |
| TOTAL | $N/A | $N/A | $87,560 | $71,810 | $68,431 |
| Total Liabilities And Equity | $0 | $0 | $278,340 | $195,031 | $223,000 |